American International Group’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-13,547
| Closed | -$52K | – | 3188 |
|
2020
Q1 | $52K | Sell |
13,547
-784
| -5% | -$3.01K | ﹤0.01% | 2666 |
|
2019
Q4 | $87K | Sell |
14,331
-120
| -0.8% | -$728 | ﹤0.01% | 2703 |
|
2019
Q3 | $109K | Buy |
14,451
+1,231
| +9% | +$9.29K | ﹤0.01% | 2563 |
|
2019
Q2 | $179K | Buy |
+13,220
| New | +$179K | ﹤0.01% | 2300 |
|
2018
Q2 | – | Sell |
-7,457
| Closed | -$65K | – | 3134 |
|
2018
Q1 | $65K | Sell |
7,457
-400
| -5% | -$3.49K | ﹤0.01% | 2833 |
|
2017
Q4 | $98K | Buy |
7,857
+213
| +3% | +$2.66K | ﹤0.01% | 2745 |
|
2017
Q3 | $64K | Buy |
7,644
+571
| +8% | +$4.78K | ﹤0.01% | 2768 |
|
2017
Q2 | $120K | Buy |
+7,073
| New | +$120K | ﹤0.01% | 2613 |
|
2016
Q2 | – | Sell |
-2,003
| Closed | -$19K | – | 4595 |
|
2016
Q1 | $19K | Buy |
+2,003
| New | +$19K | ﹤0.01% | 4321 |
|